Dissertation/ Thesis

Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease 7

التفاصيل البيبلوغرافية
العنوان: Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease 7
المؤلفون: Nishikawa, Tatsuya, Fujino, Masashi, Nakajima, Ikutaro, Asaumi, Yasuhide, Kataoka, Yu, Anzai, Toshihisa, Kusano, Kengo, Noguchi, Teruo, Goto, Yoichi, Nishimura, Kunihiro, Miyamoto, Yoshihiro, Kiso, Keisuke, Yasuda, Satoshi
المصدر: EP Europace. 19 7
سنة النشر: 2016
مصطلحات موضوعية: CTO, 植込み型除細動器, 虚血性心疾患, 血行再建, 心筋viability, Chronic total occlusion, implantable cardioverter-defibrillator, ischemic heart disease, revascularization, myocardial viability
Contents Note: Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease
虚血性心疾患患者で植込み型除細動器移植後の長期予後に及ぼす冠動脈慢性完全閉塞病変の影響 -- Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischemic heart disease
نوع الوثيقة: 博士論文
وصف الملف: application/pdf
اللغة: English
DOI: 10.1093/europace/euw213
URL الوصول: https://ndlsearch.ndl.go.jp/books/R100000039-I11115919
Degree: 博士(医学) -- 徳島大学
ملاحظات: 収集根拠 : 博士論文(自動収集)

資料形態 : テキストデータ

コレクション : 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文

Aims The prognostic impact of chronic total coronary occlusion (CTO) on implantable cardioverterdefibrillator (ICD) recipients remains unclear.Methods and Results Eighty-four consecutive patients with ischemic heart disease who received ICD therapy for primary or secondary prevention were analyzed. We investigated all-cause mortality and major adverse cardiac events (MACEs) including cardiac death, appropriate device therapy, hospitalization for heart failure, and ventricular assist device implantation. Of the study patients (mean age 70 ± 8 years; 86% men), 34 (40%) had CTO. There were no significant differences in age, left ventricular ejection fraction (LVEF), NYHA functional class III or IV status, and proportion who underwent secondary prevention between patients with CTO (CTO group) and without CTO (non-CTO group). During a median follow-up of 3.8 years (interquartile range 2.7 to 5.4 years), the CTO group tended to have a higher MACE rate (log-rank P=0.054) than the non-CTO group. Within the CTO group, there was no difference in the MACE rate between patients with and without viable myocardium. In patients with ICD for secondary prevention (n=47), 16 patients (34%) with CTO had a higher MACE rate than patients without CTO (logrank P<0.01). Cox proportional hazards regression analysis showed that the presence of CTO, but 3 not LVEF, was associated with a higher MACE rate. Multivariate analysis showed that the presence of CTO was a predictor of MACE (P<0.05).Conclusion In patients with ischemic heart disease receiving ICD implantation, the presence of CTO has an adverse impact on long-term prognosis, especially as secondary prevention.
رقم الانضمام: edsdlc.oai:ndlsearch.ndl.go.jp:R100000039.I11115919
قاعدة البيانات: National Diet Library Digital Collections - 国立国会図書館デジタルコレクション